These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10674358)

  • 1. Formation of L-alloisoleucine in vivo: an L-[13C]isoleucine study in man.
    Schadewaldt P; Bodner-Leidecker A; Hammen HW; Wendel U
    Pediatr Res; 2000 Feb; 47(2):271-7. PubMed ID: 10674358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanism of L-alloisoleucine formation: studies on a healthy subject and in fibroblasts from normals and patients with maple syrup urine disease.
    Schadewaldt P; Hammen HW; Dalle-Feste C; Wendel U
    J Inherit Metab Dis; 1990; 13(2):137-50. PubMed ID: 2116545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease.
    Schadewaldt P; Bodner-Leidecker A; Hammen HW; Wendel U
    Clin Chem; 1999 Oct; 45(10):1734-40. PubMed ID: 10508118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of R- and S-3-methyl-2-oxopentanoate enantiomers in human plasma: suitable method for label enrichment analysis.
    Schadewaldt P; Wendel U; Hammen HW
    J Chromatogr B Biomed Appl; 1996 Jul; 682(2):209-18. PubMed ID: 8844412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloisoleucine formation in maple syrup urine disease: isotopic evidence for the mechanism.
    Matthews DE; Ben-Galim E; Haymond MW; Bier DM
    Pediatr Res; 1980 Jul; 14(7):854-7. PubMed ID: 7413299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transamination and oxidative decarboxylation of L-isoleucine, L-alloisoleucine and related 2-oxo acids in perfused rat hind limb muscle.
    Schadewaldt P; Radeck W; Hammen HW; Staib W
    Biochim Biophys Acta; 1989 Jul; 992(1):115-23. PubMed ID: 2568853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Branched-chain L-amino acid metabolism in classical maple syrup urine disease after orthotopic liver transplantation.
    Bodner-Leidecker A; Wendel U; Saudubray JM; Schadewaldt P
    J Inherit Metab Dis; 2000 Dec; 23(8):805-18. PubMed ID: 11196106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of whole body L-leucine oxidation by noninvasive L-[1-13C]leucine breath tests: a reappraisal in patients with maple syrup urine disease, obligate heterozygotes, and healthy subjects.
    Schadewaldt P; Bodner A; Brösicke H; Hammen HW; Wendel U
    Pediatr Res; 1998 May; 43(5):592-600. PubMed ID: 9585004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral L-alloisoleucine loading studies in healthy subjects and in patients with maple syrup urine disease.
    Schadewaldt P; Dalle-Feste C; Langenbeck U; Wendel U
    Pediatr Res; 1991 Nov; 30(5):430-4. PubMed ID: 1754297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanisms of the formation of L-alloisoleucine and the 2-hydroxy-3-methylvaleric acid stereoisomers from L-isoleucine in maple syrup urine disease patients and in normal humans.
    Mamer OA; Reimer ML
    J Biol Chem; 1992 Nov; 267(31):22141-7. PubMed ID: 1429566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease.
    Schadewaldt P; Hammen HW; Ott AC; Wendel U
    J Inherit Metab Dis; 1999 Aug; 22(6):706-22. PubMed ID: 10472531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transamination and oxidative decarboxylation rates of branched-chain 2-oxo acids in cultured human skin fibroblasts.
    Schadewaldt P; Radeck W; Hammen HW; Wendel U
    Pediatr Res; 1988 Jan; 23(1):40-4. PubMed ID: 3340442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial synthesis of L-[15N]leucine L-[15N]isoleucine, and L-[3-13C]-and L-[3'-13C]isoleucines studied by nuclear magnetic resonance and gas chromatography-mass spectrometry.
    Kahana ZE; Gopher A; Dorsman M; Lapidot A
    Anal Biochem; 1988 Nov; 174(2):374-80. PubMed ID: 3149160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelation between the metabolism of L-isoleucine and L-allo-isoleucine in patients with maple syrup urine disease.
    Wendel U; Langenbeck U; Seakins JW
    Pediatr Res; 1989 Jan; 25(1):11-4. PubMed ID: 2919111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloisoleucine differentiates the branched-chain aminoacidemia of Zucker and dietary obese rats.
    Olson KC; Chen G; Xu Y; Hajnal A; Lynch CJ
    Obesity (Silver Spring); 2014 May; 22(5):1212-5. PubMed ID: 24415721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15N conservation in the metabolic conversion of isoleucine to alloisoleucine in the rat.
    Mamer OA; Lépine FL
    J Mass Spectrom; 1996 Dec; 31(12):1382-8. PubMed ID: 8990521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of (S)- and (R)-2-oxo-3-methylvaleric acid in plasma of patients with maple syrup urine disease.
    Wendel U; Even G; Langenbeck U; Schadewaldt P; Hummel W
    Clin Chim Acta; 1992 Jun; 208(1-2):85-91. PubMed ID: 1638756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic annotation of 2-ethylhydracrylic acid.
    Ryan RO
    Clin Chim Acta; 2015 Aug; 448():91-7. PubMed ID: 26115894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biogenetic origin of the D-isoleucine and N-methyl-L-alloisoleucine residues in the actinomycins.
    Yajima T; Mason K; Katz E
    Antimicrob Agents Chemother; 1976 Feb; 9(2):224-32. PubMed ID: 57739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of plasma leucine and alpha-ketoisocaproate during a L-[1-13C]leucine infusion in man: a method for measuring human intracellular leucine tracer enrichment.
    Matthews DE; Schwarz HP; Yang RD; Motil KJ; Young VR; Bier DM
    Metabolism; 1982 Nov; 31(11):1105-12. PubMed ID: 7132737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.